Troubleshooting Agile Lean Startup in Large Organizations Part I
5 snips
Feb 16, 2022 Join Jim Euchner, author and innovation expert, as he dives into the challenges of fostering innovation in large organizations. He unveils the concept of 'antibodies'—the resistance to experimentation—and explains why they can be beneficial. Jim discusses how lean startup principles can be effectively adapted to corporate settings, emphasizing the balance between control and innovation. He also examines the hurdles faced during iterative development and the importance of understanding organizational dynamics to achieve sustainable growth.
AI Snips
Chapters
Books
Transcript
Episode notes
Corporate Antibodies
- Large companies struggle with Lean Startup principles because they trigger internal resistance.
- These "antibodies" are healthy responses to perceived threats to established processes.
Clash of Methodologies
- Lean Startup's iterative nature clashes with the traditional successive refinement approach.
- This creates fear and anxiety within large organizations accustomed to predictable, linear processes.
Managing Fears of Chaos
- Manage fears of chaos by implementing a hybrid innovation stage-gate process.
- This provides structure and clear deliverables for review, reducing uncertainty in corporate settings.
